Skip to main content
OpenTrials
Completed

NCT Number: NCT01769118

The Influences of Caffeine on Heart Rate Variability of Preterm Infants

Caffeine has a stimulatory effect on the ANS. This has not yet been investigated in preterm infant who get caffeine before stopping ventilation. The investigators hypothesis is that this stimulatory effect may be characterized by HRV analysis methods.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 week–34 week

Sex eligibility

All sexes

Study type

Observational

Primary location

RMC

Haifa, Israel

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • infants born before 34 weeks gestation

Exclusion criteria

  • sepsis
  • congenital malformations

Treatment and study plan

Caffeine

Drug

Caffeine will be given according to departmental protocol

Primary outcomes

  1. Heart rate variability

    Time frame: 1 hour

    Heart rate, SD, SDNN, HF, LF, VLF, TP

Sponsors and collaborators

Lead sponsor

Rambam Health Care Campus

Other

Registry information

Official study title

The Influences of Caffeine on HRV of Preterm Infants

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Jan 16, 2013
Registry last updated
May 8, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.